Atossa to Issue CVRs Giving Shareholders Claim on 25% of First Voucher Proceeds, Capped at $50M

Atossa will issue one contingent value right per share giving holders a contractual claim to 25% of net proceeds from the company's first qualifying rare pediatric disease priority review voucher, capped at $50 million.Key Highlights:Original SEC Filing: ATOSSA THERAPEUTICS, INC. [ ATOS ] - 8-K - S…